RecruitingNCT04257877

Proteomic Analysis in Paediatric Diabetes Type 1 (PAPD)

Targeted Proteomic Analysis in the Plasma of Children With Diabetes Type 1 and Its Association With Peripheral Diabetic Neuropathy


Sponsor

Aristotle University Of Thessaloniki

Enrollment

50 participants

Start Date

Nov 20, 2018

Study Type

OBSERVATIONAL

Conditions

Summary

The aim of the present study is to investigate a targeted proteomic analysis in plasma of children - of Greek origin- with type 1 diabetes (DT1) and its correlation with the electrophysiological findings that accompany diabetic peripheral neuropathy. Diabetic neuropathy is the most frequent chronic complication in adults with DT1 and rarely appears in childhood. Nevertheless, cases of acute mononeuritis have been described at the time of diagnosis of DT1. According to recent reports several biomarkers, including proteomic analysis, have been proposed for the early detection of peripheral neuropathy in children and young adults with T1DM. In the present study the researchers will attempt to investigate the role of biomarkers with targeted proteomic analysis in the plasma of children with DT1 in combination with an electrophysiological study, which includes a nerve conduction study, to detect early diabetic peripheral neuropathy, before the appearance of clinical manifestations.


Eligibility

Min Age: 5 YearsMax Age: 10 Years

Plain Language Summary

Simplified for easier understanding

This study is analyzing proteins in the blood (called proteomics) of children with well-controlled Type 1 diabetes to look for early biological markers of nerve damage (neuropathy), even before any symptoms appear. **You may be eligible if:** - Your child has confirmed Type 1 diabetes and is taking insulin - Your child is between 5 and 10 years old and has not yet started puberty - Diabetes is well-controlled, with an HbA1c (average blood sugar measure) of 7.0% or below - Your child has no other chronic illnesses **You may NOT be eligible if:** - There is an identified organic (physical) cause for nerve damage - Your child has another chronic illness - Blood sugar control is poor Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

PROCEDUREBlood sampling

Blood samples for proteomic analysis in plasma of both groups


Locations(1)

Unit of Pediatric Endocrinology, Diabetes and Metabolism-2nd Department of Pediatrics, School of Medicine, Faculty of Health Sciences, Aristotle University of Thessaloniki

Thessaloniki, Greece

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT04257877


Related Trials